Dimensional Fund Advisors LP increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 18.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 539,981 shares of the medical instruments supplier's stock after acquiring an additional 82,982 shares during the quarter. Dimensional Fund Advisors LP owned about 2.21% of ICU Medical worth $83,788,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the company. Barclays PLC boosted its position in shares of ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock worth $10,790,000 after purchasing an additional 8,010 shares in the last quarter. Principal Financial Group Inc. raised its stake in ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after buying an additional 25,031 shares during the period. Vanguard Group Inc. lifted its holdings in ICU Medical by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock worth $416,176,000 after acquiring an additional 17,805 shares in the last quarter. Jennison Associates LLC acquired a new position in ICU Medical in the fourth quarter valued at about $556,000. Finally, Franklin Resources Inc. increased its holdings in shares of ICU Medical by 99.3% in the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after acquiring an additional 5,834 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.
ICU Medical Stock Down 2.4 %
Shares of ICUI stock traded down $3.42 during trading on Monday, reaching $138.23. The company's stock had a trading volume of 17,716 shares, compared to its average volume of 273,724. ICU Medical, Inc. has a one year low of $96.97 and a one year high of $196.26. The business has a fifty day moving average price of $141.61 and a 200-day moving average price of $156.43. The company has a market cap of $3.40 billion, a price-to-earnings ratio of -30.20 and a beta of 0.86. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on ICUI. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Friday. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. KeyCorp lowered their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, Raymond James set a $97.00 price target on ICU Medical in a report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $162.67.
Read Our Latest Stock Report on ICUI
ICU Medical Profile
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Featured Stories

Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.